Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Fund Update: New $124.0M $BAC stock position opened by CCLA Investment Management

None

CCLA Investment Management has opened a new $124.0M position in $BAC, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 12-31-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $BAC.

$BAC Hedge Fund Activity

We have seen 1,610 institutional investors add shares of $BAC stock to their portfolio, and 1,425 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$BAC Insider Trading Activity

BAC Insider Trades

$BAC insiders have traded $BAC stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $BAC stock by insiders over the last 6 months:

  • JAMES P DEMARE (President, Global Markets) sold 148,391 shares for an estimated $6,761,732

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$BAC Congressional Stock Trading

Members of Congress have traded $BAC stock 7 times in the past 6 months. Of those trades, 1 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $BAC stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$BAC Analyst Ratings

Wall Street analysts have issued reports on $BAC in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • TD Cowen issued a "Buy" rating on 01/15/2026
  • Keefe, Bruyette & Woods issued a "Outperform" rating on 01/15/2026
  • Truist Securities issued a "Buy" rating on 01/15/2026
  • CICC issued a "Outperform" rating on 01/14/2026
  • Goldman Sachs issued a "Buy" rating on 01/06/2026
  • Barclays issued a "Overweight" rating on 01/05/2026
  • Oppenheimer issued a "Outperform" rating on 11/19/2025

To track analyst ratings and price targets for $BAC, check out Quiver Quantitative's $BAC forecast page.

$BAC Price Targets

Multiple analysts have issued price targets for $BAC recently. We have seen 13 analysts offer price targets for $BAC in the last 6 months, with a median target of $62.0.

Here are some recent targets:

  • Betsy Graseck from Morgan Stanley set a target price of $64.0 on 01/15/2026
  • Christopher McGratty from Keefe, Bruyette & Woods set a target price of $63.0 on 01/15/2026
  • Scott Siefers from Piper Sandler set a target price of $57.0 on 01/15/2026
  • Steven Alexopoulos from TD Cowen set a target price of $64.0 on 01/15/2026
  • Glenn Schorr from Evercore ISI Group set a target price of $59.0 on 01/15/2026
  • John McDonald from Truist Securities set a target price of $60.0 on 01/15/2026
  • An analyst from CICC set a target price of $62.0 on 01/14/2026

Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.

Check out Quiver Quantitative's $BAC ticker page for more data.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles